Results 221 to 230 of about 105,425 (257)

Histone deacetylase inhibitors: discovery and development as anticancer agents

Expert Opinion on Investigational Drugs, 2005
Miloš Dokmanović, Paul A Marks
exaly  

Zinc binding groups for histone deacetylase inhibitors

Journal of Enzyme Inhibition and Medicinal Chemistry, 2018
Qixiao Jiang
exaly  

Targeting histone deacetylase in cancer therapy

Medicinal Research Reviews, 2006
Jing-Ru Weng
exaly  

Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC)

Annals of Oncology, 2010
Gerhardt Attard, L R Molife, P C Fong
exaly  

Histone deacetylase inhibitors: from target to clinical trials

Expert Opinion on Investigational Drugs, 2002
Paul A Marks, Owen A O’Connor
exaly  

INHIBITORS OF HISTONE DEACETYLASE

2008
GRIMM JONATHAN B, HUBBS JED L, MILLER THOMAS, OTTE KARIN M, SILIPHAIVANH PHIENG, STANTON MATTHEW G, WILSON KEVIN, WITTER DAVID, ZHOU HUA   +8 more
  +19 more sources

Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro

Cancers, 2019
Serene Lee, Anja Bosserhoff, Claus Hellerbrand   +2 more
exaly  

HISTONE DEACETYLASE INHIBITORS

2006
MOFFAT DAVID FESTUS CHARLES, PATEL SANJAY RATILAL, MAZZEI FRANCESCA ANN, BELFIELD ANDREW JAMES, VAN MEURS SANDRA   +4 more
openaire   +6 more sources

Histone Deacetylase 11 Is an ε-N-Myristoyllysine Hydrolase

Cell Chemical Biology, 2018
Andreas Stahl Madsen, Christian Adam Olsen, Iacopo Galleano   +2 more
exaly  

Inhibitors of Histone Deacetylase

2014
HOLSON EDWARD, WAGNER FLORENCE FEVRIER, WEIWER MICHEL, TSAI LI-HUEI, HAGGARTY STEPHEN, ZHANG YAN-LING   +5 more
openaire   +10 more sources